Reduction in the magnitude of serum potassium elevation in combination therapy with esaxerenone (CS‐3150) and sodium–glucose cotransporter 2 inhibitor in patients with diabetic kidney disease: Subanalysis of two phase III studies
Shikata, Kenichi ; Ito, Sadayoshi ; Kashihara, Naoki ; Nangaku, Masaomi ; Wada, Takashi ; Okuda, Yasuyuki ; Sawanobori, Tomoko ; Sugimoto, Kotaro
Journal of Cutaneous Immunology and Allergy, 2022-07, Vol.13 (7), p.1190-1202 [Periódico revisado por pares]Japan: John Wiley & Sons, Inc
Texto completo disponível